[1]MATTHEW G,TIMOTHY S,RICHARD KAPLAN,et al.Comprehensive analysis of colorectal cancer-risk loci and survival outcome:A prognostic role for CDH1 variants[J].European Journal of Cancer,2020,124:56-63.
[2]PERNILLE GABEL,ADRIAN EDWARDS,PIA KIRKEGAARD,et al.The LEAD trial-The effectiveness of a decision aid on decision making among citizens with lower educational attainment who have not participated in FIT-based colorectal cancer screening in Denmark:A randomized controlled trial[J].Patient Education and Counseling,2020,103(2):359-368.
[3]周琴,梁颖茹,李燕,等.广州市人群2015-2017年大粪便免疫化学检测成本分析[J].中国肿瘤,2019,28(04):257-263.
ZHOU Q,LIANG YR,LI Y,et al.Cost analysis of colorectal cancer screening in Guangzhou population from 2015 to 2017 [J].Cancer in China,2019,28(04):257-263.
[4]REBECCA L SIEGEL,KIMBERLY D MILLER,AHMEDIN JEMAL.Cancer statistics,2019[J].CA:A Cancer Journal for Clinicians,2019,69(1):7-34.
[5]BONNIE GANCE-CLEVELAND,ANNA LINTON,JARON ARBET,et al.Predictors of overweight and obesity in childhood cancer survivors[J].J Pediatr Oncol Nurs,2020,37(3):154-162.
[6]陈琦玲.特殊类型高血压临床诊治要点专家建议[J].中国全科医学,2020,23(10):1202-1228.
CHEN QL.Expert advice on clinical diagnosis and treatment of special type hypertension[J].China General Practice Medicine,2020,23(10):1202-1228.
[7]钟桂兰,王小花,符山花.拉贝洛尔对妊娠高血压综合征病人CRP、CysC水平及分娩结局的影响[J].中西医结合心脑血管病杂志,2020,18(02):306-309.
ZHONG GL,WANG XH,FU SH.Effects of labelor on CRP and CysC levels and delivery outcomes in patients with gestational hypertension syndrome [J].Journal of Cardiovascular and Cerebrovascular Diseases of Integrated Traditional Chinese and Western Medicine,2020,18(02):306-309.
[8]郭利伟,黄艳梅,祁英,等.肿瘤坏死因子α基因-238G>A及-857C>T多态性与河南汉族群体原发性高血压[J].河南师范大学学报:自然科学版,2011,39(3):126-130.
GUO LW,HUANG YM,QI Y,et al.The polymorphism of tumor necrosis factor gene - 238G > A and - 857C>T and primary hypertension in Henan Han population[J].Journal of Henan Normal University:Natural Science Edition,2011,39(3):126-130.
[9]张楠楠,高超,邱渝杰,等.肥胖与癌症关系的临床研究最新进展[J].医学综述,2014,20(08):1401-1403.
ZHANG NN,GAO C,QIU YJ,et al.Recent progress in clinical research on the relationship between obesity and cancer [J].Medical Review,2014,20(08):1401-1403.
[10]倪宇,徐洪雨.肥胖与结直肠腺瘤和结直肠癌关系的研究[J].胃肠病学和肝病学杂志,2019,28(05):499-502.
NI Y,XU HY.The relationship between obesity,colorectal adenoma and colorectal cancer [J].Gastroenterology and Hepatology,2019,28(05):499-502.
[11]郭艳,陈雪松.EGCG抗肿瘤作用及其相关靶点的研究进展[J].现代肿瘤医学,2019,27(2):331-335.
GUO Y,CHEN XS.Research progress on the anti-tumor effect of EGCG and its related targets[J].Modern Oncology,2019,27(2):331-335.
[12]徐传洋,王昭维,何磊,等.肥胖及代谢相关疾病治疗新靶点GDF15/GFRAL信号通路的研究进展[J].中国医药导报,2019,16(18):25-29.
XU CY,WANG CW,HE L,et al.Research progress of GDF15 / GFRAL signaling pathway,a novel therapeutic target for obesity and metabolic diseases [J].China Journal of Medicine,2019,16(18):25-29.
[13]陈秀清,杨立勇,沈喜妹,等.代谢综合征及其组分与结直肠癌根治术后转移复发的相关性[J].中国老年学杂志,2019,39(16):3934-3937.
CHEN XQ,YANG LY,SHEN XM,et al.Correlation between metabolic syndrome and its components and recurrence of metastasis after radical resection of colorectal cancer [J].Chinese Journal of Gerontology,2019,39(16):3934-3937.
[14]TAKAFUMI TAMURA,SATOSHI INAGAWA,KATSUJI HISAKURA,et al.Evaluation of serum high-density lipoprotein cholesterol levels as a prognostic factor in gastric cancer patients[J].Journal of Gastroenterology and Hepatology,2012,27(10):1635-1640.
[15]张建,杜依青,刘苗雨,等.脂质代谢异常与肾细胞癌相关性的研究进展[J].临床泌尿外科杂志,2018,33(5):413-417.
ZHANG J,DU YQ,LIU MY,et al.Advances in the study of the relationship between abnormal lipid metabolism and Renal Cell Carcinoma [J].Journal of Clinical Urology,2018,33(5):413-417.
[16]王俊.高脂血症与结直肠肿瘤的研究进展[J].检验医学与临床,2017,14(Z1):365-368.
WANG J.Research progress of hyperlipidemia and colorectal tumor [J].Laboratory Medicine and Clinical Medicine,2017,14(Z1):365-368.
[17]FLISS-ISAKOV NAOMI,ZELBER-SAGI SHIRA,WEBB MURIEL,et al.Distinct metabolic profiles are associated with colorectal adenomas and serrated polyps[J].Obesity (Silver Spring,Md.),2017,25 Suppl 2:72-80.
[18]WANG Y,SUN XQ,LIN HC.Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer[J].Cancer Medicine,2019,8(3):1209-1217.
[19]MATTEO PIRRO,BIAGIO RICCIUTI,DANIEL J RADER,et al.High density lipoprotein cholesterol and cancer:Marker or causative[J].Progress in Lipid Research,2018,71:54-69.